Cotización Alpha Teknova - TKNO

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Último Precio

7.74

Postura de Compra

7.55

Postura de Venta

7.90

Volume Operado de la Acción

0.00 Rango del Día 0.00

1.155 Rango de 52 semanas 8.36

Capitalización de Mercado [m]

412.602M

Precio Anterior

7.74

Precio de Apertura

Hora

7.74

Última hora de negociación

03:31:56

Volumen financiero

Precio Promedio Ponderado

Volumen promedio (3 m)

215,935

Acciones en circulación

53,307,689

Rendimiento del Dividendo

Ratio Precio/Utilidad

-11.22

Beneficio por acción (BPA)

-0.69

turnover

36.68M

Beneficio neto

-36.78M

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture ... Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. Mostrar más

Sector

In Vitro,in Vivo Diagnostics

Industria

In Vitro,in Vivo Diagnostics

Sitio web

www.teknova.com

Sede

Wilmington, Delaware, USA

Fundado

Alpha Teknova Inc is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker TKNO. The last closing price for Alpha Teknova was US$7.74. Over the last year, Alpha Teknova shares have traded in a share price range of US$ 1.155 to US$ 8.36.

Alpha Teknova currently has 53,307,689 shares in issue. The market capitalisation of Alpha Teknova is US$412.60 million. Alpha Teknova has a price to earnings ratio (PE ratio) of -11.22.

Teknova Introduces Proprietary Express-Tek℠ Production Service and Expanded Manufacturing Grade Options to Expedite Novel Therapy Development

Express-TekSM Production enables customers to have their products enter production in days instead of weeks, significantly shortening turnaround time New manufacturing grade, RUO+, provides a...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	1.37	21.5070643642	6.37	8.36	5.64	360864	6.7878662	CS
4	1.41	22.2748815166	6.33	8.36	5.64	298517	6.83423566	CS
12	3.02	63.9830508475	4.72	8.36	4	215935	6.10504997	CS
26	5.96	334.831460674	1.78	8.36	1.155	390745	3.59692273	CS
52	5.68	275.72815534	2.06	8.36	1.155	207729	3.5703947	CS
156	-17.24	-69.0152121697	24.98	25.78	1.155	112087	4.72028697	CS
260	-12.98	-62.6447876448	20.72	30.89	1.155	115759	7.46848734	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
WORXSCWorx Corporation	US$ 1.85 (88.78%)	14.78M
AKTSAkoustis Technologies Inc	US$ 0.12985 (49.08%)	52.03M
PETWag Group Company	US$ 0.312 (48.50%)	16.27M
CRKNCrown Electrokinetics Corporation	US$ 1.13 (43.83%)	4.35M
ESGROEnstar Group Ltd	US$ 28.00 (40.92%)	24
WSBFWaterstone Financial Inc	US$ 9.00 (-40.98%)	4
TRSTriMas Corporation	US$ 15.62 (-40.79%)	3
BCAXBicara Therapeutics Inc	US$ 11.00 (-40.15%)	208
XNCRXencor Inc	US$ 15.11 (-36.30%)	2
PYXSPyxis Oncology Inc	US$ 2.44 (-36.13%)	201.93k
AKTSAkoustis Technologies Inc	US$ 0.12985 (49.08%)	52.03M
PETWag Group Company	US$ 0.312 (48.50%)	16.27M
WORXSCWorx Corporation	US$ 1.85 (88.78%)	14.78M
XTKGX3 Holdings Company Ltd	US$ 0.0797 (-11.44%)	10.59M
CRKNCrown Electrokinetics Corporation	US$ 1.13 (43.83%)	4.35M